IRIS
DI CHIO, Carla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 407
NA - Nord America 308
AS - Asia 27
AF - Africa 2
Totale 744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 308
IE - Irlanda 125
IT - Italia 118
SE - Svezia 68
AT - Austria 56
PL - Polonia 30
CN - Cina 21
FR - Francia 4
DE - Germania 3
FI - Finlandia 3
KW - Kuwait 2
NG - Nigeria 2
VN - Vietnam 2
AM - Armenia 1
IN - India 1
Totale 744
Salva come PNG Salva come JPEG
Città #
Dublin 125
Chandler 119
Nyköping 65
Vienna 56
Messina 31
Warsaw 30
Ashburn 25
Princeton 18
Medford 15
Des Moines 12
Beijing 8
Siderno 7
Francavilla di Sicilia 6
Rome 5
Cagliari 4
Catania 3
Groß-umstadt 3
Lentini 3
Leonforte 3
Nocera Terinese 3
Bari 2
Caltagirone 2
Dong Ket 2
Dongguan 2
Ferrara 2
Hebei 2
Helsinki 2
Jinan 2
Katsina 2
Kuwait City 2
Milan 2
Palermo 2
Riposto 2
Shenyang 2
Turin 2
Boardman 1
Gravina di Catania 1
Haikou 1
Houston 1
Hyderabad 1
Jacksonville 1
Jiaxing 1
Ningbo 1
Piazza Armerina 1
Redmond 1
Riesi 1
Rosarno 1
Scordia 1
Seattle 1
Taizhou 1
Trecastagni 1
Wilmington 1
Yerevan 1
Zhengzhou 1
Totale 590
Salva come PNG Salva come JPEG
Nome #
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 86
Design, synthesis and biological evaluation of novel bioactive molecules for the treatment of protozoan and human diseases 67
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 54
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 52
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 50
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 46
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 44
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 43
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 40
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 29
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 29
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 29
Discovery of novel antitrypanosomal agents: design, synthesis of novel benzodiazepine-based peptidomimetics targeting rhodesain, the main cysteine protease of Trypanosoma brucei rhodesiense 28
null 27
Dual inhibition of parasitic targets: a valuable strategy to treat malaria and neglected tropical diseases 23
null 21
Drug combination studies of the dipeptide nitrile CD24 with curcumin: a new strategy to synergistically inhibit rhodesain of trypanosoma brucei rhodesiense 20
Falcipain-2 and Falcipain-3 Inhibitors as Promising Antimalarial Agents 19
Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense 19
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 18
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 16
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 13
Monoclonal antibodies: the greatest resource to treat multiple myeloma 12
null 11
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 11
null 9
Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis 6
Dihydrochalcones as antitumor agents. 6
Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome 5
Synthesis and cytotoxicity of diarylpentanoids against sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells 2
Totale 835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.331
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 0 1 6 0 2 11 7 9
2020/202171 2 4 9 3 11 14 7 2 8 7 2 2
2021/2022116 5 2 1 9 9 4 3 2 8 3 12 58
2022/2023472 19 54 20 45 35 50 18 36 143 5 41 6
2023/2024140 34 17 6 31 10 2 1 5 4 12 18 0
Totale 835